KROS Market Cap History



Below is a table of the KROS market cap history going back to 4/8/2020:

Date KROS Market Cap
4/8/2020365.24M
5/15/2020576.25M
8/7/2020732.26M
11/3/20201.07B
3/19/20211.38B
4/29/20211.63B
7/27/2021854.17M
10/28/2021987.89M
3/2/20221.25B
4/29/20221.27B
7/29/2022826.28M
10/27/20221.32B
2/23/20231.54B
4/27/20231.30B
7/28/20231.24B
10/31/2023855.04M

Also see: KROS Shares Outstanding History
and KROS YTD Return
KROS Historical Market Cap:
+26.95% CAGR
KROS Historical Market Cap: +26.95% CAGR

Mouse over chart for data details
4/8/2020 ...10/31/2023
Keros Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of treatments for hematological, pulmonary and cardiovascular disorders. Co.'s protein therapeutic product candidate, KER-050, is developed for the treatment of low blood cell counts, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, and in patients with myelofibrosis. Co.'s small molecule product candidate, KER-047, is developed for the treatment of functional iron deficiency. Co.'s third product candidate, KER-012, is developed for the treatment of pulmonary arterial hypertension, and for the treatment of cardiovascular disorders. We show 16 historical shares outstanding datapoints in our KROS shares outstanding history coverage, used to compute KROS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing KROS market cap history over the course of time is important for investors interested in comparing KROS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of KROS versus a peer is one thing; comparing KROS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like KROS can fluctuate over the course of history. With this page we aim to empower investors researching KROS by allowing them to research the KROS market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree KROS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Keros Therapeutics (KROS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

KRTX Market Cap History
KRYS Market Cap History
KTRA Market Cap History
KTTA Market Cap History
KTWO Market Cap History
KURA Market Cap History
KYMR Market Cap History
KZR Market Cap History
LAB Market Cap History
LABP Market Cap History
More Healthcare companies »

 

KROS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.